Current State of Immunotherapy for Treatment of Glioblastoma

At this time, there are no FDA-approved immune therapies for glioblastoma (GBM) despite many unique therapies currently in clinical trials. GBM is a highly immunosuppressive tumor and there are limitations to a safe immune response in the central nervous system. To date, there have been several fail...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Treat Options Oncol
Main Authors: McGranahan, Tresa, Therkelsen, Kate Elizabeth, Ahmad, Sarah, Nagpal, Seema
Format: Artigo
Sprog:Inglês
Udgivet: Springer US 2019
Fag:
Neuro-oncology (GJ Lesser, Section Editor)
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6394457/
https://ncbi.nlm.nih.gov/pubmed/30790064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-019-0619-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker